Literature DB >> 9020362

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

A Kauffmann-Zeh1, P Rodriguez-Viciana, E Ulrich, C Gilbert, P Coffer, J Downward, G Evan.   

Abstract

The viability of vertebrate cells depends on survival factors which activate signal transduction pathways that suppress apoptosis. Defects in anti-apoptotic signalling pathways are implicated in many pathologies including cancer, in which apoptosis induced by deregulated oncogenes must be forestalled for a tumour to become established. Phosphatidylinositol-3-kinase (PI(3)K) is involved in the intracellular signal transduction of many receptors and has been implicated in the transduction of survival signals in neuronal cells. We therefore examined the role of PI(3)K, its upstream effector Ras, and its putative downstream protein kinase effectors PKB/Akt and p70S6K (ref. 5) in the modulation of apoptosis induced in fibroblasts by the oncoprotein c-Myc. Here we show that Ras activation of PI(3)K suppresses c-Myc-induced apoptosis through the activation of PKB/Akt but not p70S6K. However, we also found that Ras is an effective promoter of apoptosis, through the Raf pathway. Thus Ras activates contradictory intracellular pathways that modulate cell viability. Induction of apoptosis by Ras may be an important factor in limiting the expansion of somatic cells that sustain oncogenic ras mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020362     DOI: 10.1038/385544a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  243 in total

1.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.

Authors:  P Juin; A O Hueber; T Littlewood; G Evan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells.

Authors:  S Sarner; R Kozma; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.

Authors:  S G Kennedy; E S Kandel; T K Cross; N Hay
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

4.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  Suppression of Ras-induced apoptosis by the Rac GTPase.

Authors:  T Joneson; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling.

Authors:  A Takakura; J Miyoshi; H Ishizaki; M Tanaka; A Togawa; Y Nishizawa; H Yoshida; S i Nishikawa; Y Takai
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

9.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

10.  alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway.

Authors:  J W Lee; R L Juliano
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.